Report: COVID-19 infection fatality ratio estimates from seroprevalence
Report 34 – COVID-19 Infection Fatality Ratio Estimates from Seroprevalence – Imperial College London Full report: COVID-19 Infection Fatality Ratio: Estimates from Seroprevalence Commentary on Twitter UPDATE #COVID19 Infection Fatality Ratio (IFR): ➡️1.15% IFR (high income countries) ➡️0.23% IFR (low income countries)➡️0.1% IFR (under 40 year olds)➡️5.6% IFR (over 80 year olds)➡️Risk of COVID19 […]
The post Report: COVID-19 infection fatality ratio estimates from seroprevalence appeared first on Links Medicus.
Ten tips to optimize weaning and extubation success in the critically ill
Ten tips to optimize weaning and extubation success in the critically ill – Intensive Care Medicine Commentary on Twitter Wean/extubate critically ills1⃣optimize (⬇️) sedation2⃣diaphragm-protective MV3⃣daily screen for SBT4⃣best SBT?5⃣weaning strategy6⃣what if SBT fails7⃣muscle load/efficiency ratio8⃣weaning/extubation failure9⃣post-extubation support? tracheostomyhttps://t.co/TaYdzMvisK pic.twitter.com/q9qQOVKioZ — Intens Care Med (@yourICM) October 27, 2020
The post Ten tips to optimize weaning and extubation success in the critically ill appeared first on Links Medicus.
Randomized trial: Osimertinib in resected EGFR-Mutated non–small-cell lung cancer
Osimertinib in Resected EGFR-Mutated Non–Small-Cell Lung Cancer – New England Journal of Medicine
The post Randomized trial: Osimertinib in resected EGFR-Mutated non–small-cell lung cancer appeared first on Links Medicus.
Video: Coronavirus update with Anthony Fauci – October 28, 2020
Coronavirus Update With Anthony Fauci – October 28, 2020 – JAMA
The post Video: Coronavirus update with Anthony Fauci – October 28, 2020 appeared first on Links Medicus.
Clinical practice: Mild or moderate Covid-19
Mild or Moderate Covid-19 – New England Journal of Medicine
The post Clinical practice: Mild or moderate Covid-19 appeared first on Links Medicus.
Randomized phase 2 trial: SARS-CoV-2 neutralizing antibody LY-CoV555 in outpatients with Covid-19
SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19 – New England Journal of Medicine Audio Interview: A New Monoclonal Antibody for Covid-19 – New England Journal of Medicine Commentaries on Twitter BLAZE-1? – outpatient trial of LY-Cov555, mAb recently dropped from ACTIV-3 inpatient trial Only 1 of the 3 mAb dosages (middle one ?♂️) […]
The post Randomized phase 2 trial: SARS-CoV-2 neutralizing antibody LY-CoV555 in outpatients with Covid-19 appeared first on Links Medicus.
Chest CT in COVID-19: What the radiologist needs to know
Chest CT in COVID-19: What the Radiologist Needs to Know – RadioGraphics
The post Chest CT in COVID-19: What the radiologist needs to know appeared first on Links Medicus.
Lilly antibody drug fails in a Covid-19 study; others go on
Lilly antibody drug fails in a Covid-19 study; others go on – CNBC
The post Lilly antibody drug fails in a Covid-19 study; others go on appeared first on Links Medicus.
Outpatient management of COVID-19: Rapid evidence review
Outpatient Management of COVID-19: Rapid Evidence Review – American Family Physician
The post Outpatient management of COVID-19: Rapid evidence review appeared first on Links Medicus.
COVID-19 – Lessons learned and questions remaining
COVID-19 – Lessons Learned and Questions Remaining – Clinical Infectious Diseases Commentary on Twitter ?Excellent article?COVID-19 – Lessons Learned and Questions Remaining@CarlosdelRio7 @davidantibiotic https://t.co/c0VG4yyJXO pic.twitter.com/7Bxn1mVttT — Antibiotic Steward? Bassam Ghanem (@ABsteward) October 26, 2020
The post COVID-19 – Lessons learned and questions remaining appeared first on Links Medicus.